These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1726999)

  • 1. [A retrospective study of the serum CEA, AFP, TPA and ferritin values in 500 patients with chronic liver diseases].
    Cioffi M; Fratta M; De Lucia D; Bresciani F
    Arch Monaldi Mal Torace; 1990; 45(3):159-65. PubMed ID: 1726999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Timor J; Thambyrajah V
    Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ferritin in hepatocellular carcinoma.
    Zhou XD; Stahlhut MW; Hann HL; London WT
    Hepatogastroenterology; 1988 Feb; 35(1):1-4. PubMed ID: 2452122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic utility of serum ferritin. Estimation in patients with primary hepatocellular carcinoma.
    Ola SO; Akanji AO; Ayoola EA
    Trop Geogr Med; 1995; 47(6):302-4. PubMed ID: 8650746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor markers in focal and diffuse liver diseases].
    Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
    Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum ferritin in patients with malignant neoplasms].
    Hoshi H; Nakayama S; Kodama T; Jinnouchi S; Nishikawa K; Wakuta Y; Kakitsubata Y; Kusuhara T; Watanabe K
    Radioisotopes; 1983 Jan; 32(1):13-7. PubMed ID: 6190199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cardiopulmonary resuscitation on levels of tumour markers.
    Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
    Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of serum ferritin level in testicular tumors].
    Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
    Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential tumor markers and hepatitis markers profile in liver tumors.
    Khalifa A; Mady EA; Abadeer N; Kamal A
    Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limits of CEA and ferritin in the diagnosis of pancreatic cancer.
    Plebani M; Fabris C; Basso D; Del Favero G; Angonese C; Leandro G; Di Mario F; Burlina A; Naccarato R
    Int J Pancreatol; 1988; 3 Suppl 1():S113-7. PubMed ID: 3209864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
    Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum ferritin in patients with hepatobiliary diseases (author's transl)].
    Uchiyama Y; Kanazawa S; Okuda K
    Rinsho Ketsueki; 1980 Aug; 21(8):1104-11. PubMed ID: 6160268
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic value of 5'nucleotidase in primary and secondary neoplasms of the liver].
    Tozzoli R; Risaliti A; Bacelle L; Perosa A; Formentini V; Bruno G; Calandra A
    Chir Ital; 1988 Apr; 40(2):146-51. PubMed ID: 2458852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
    Findeisen R; Albrecht S; Richter B; Deutschmann K; Zimmermann T; Distler W
    Luminescence; 2000; 15(5):283-9. PubMed ID: 11038485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
    Eskelinen M; Kataja V; Hämäläinen E; Kosma VM; Penttilä I; Alhava E
    Anticancer Res; 1997; 17(2B):1231-4. PubMed ID: 9137478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies].
    Koizumi F; Nakamura E; Kawamura T; Ishimori A; Hoshi S; Matsuda S
    Rinsho Byori; 1986 Sep; 34(9):1053-8. PubMed ID: 2432295
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoprotein.
    Huber K; Kirchheimer JC; Ermler D; Bell C; Binder BR
    Cancer Res; 1992 Apr; 52(7):1717-20. PubMed ID: 1372529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
    Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
    Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of radioassays for calcitonin, CEA-S, AFP and ferritin as tumor markers (author's transl)].
    Morita R; Yoshii M
    Rinsho Hoshasen; 1979 Jul; 24(7):755-61. PubMed ID: 90180
    [No Abstract]   [Full Text] [Related]  

  • 20. Usefulness of examination of some tumor markers in diagnostics of liver cancer.
    Snarska J; Szajda SD; Puchalski Z; Szmitkowski M; Chabielska E; Kaminski F; Zwierz P; Zwierz K
    Hepatogastroenterology; 2006; 53(68):271-4. PubMed ID: 16608038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.